Marked genomic differences characterize primary and secondary glioblastoma subtypes and identify two distinct molecular and clinical secondary glioblastoma entities.

Source:http://linkedlifedata.com/resource/pubmed/id/17114236

Cancer Res. 2006 Dec 1 66 23 11502-13

Download in:

View as

General Info

PMID
17114236